This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lessl, M. Articles by Fuhrmann, U. Search for Related Content PubMed PubMed Citation Articles by Lessl, M. Articles by Fuhrmann, U. Pubmed/NCBI databases OMIM Substance via MeSH Medline Plus Health Information Uterine Cancer Uterine Fibroids

Comparative Messenger Ribonucleic Acid Analysis of Immediate Early Genes and Sex Steroid Receptors in Human Leiomyoma and Healthy Myometrium

Research Laboratories of Schering AG (M.L., M.K., S.S., K.S., U.F.), 13342 Berlin, Germany; and Virchow Klinikum (A.R.), 13353 Berlin, Germany

Address all correspondence and requests for reprints to: Dr. Monika Lessl, Research Laboratories of Schering AG, Strategic Business Unit Fertility Control and Hormone Therapy, Müllerstr. 170–78, 13342 Berlin, Germany.

To shed light on the molecular mechanisms involved in the pathogenesis of uterine leiomyomas, transcript levels of the immediate early genes c-fos, c-myc, and c-jun and of the estrogen receptor (ER) and progesterone receptor (PR) were determined in tissue samples of human myometrium and leiomyoma. The messenger RNA (mRNA) content was analyzed by RT-PCR. mRNAs for c-fos, c-myc, c-jun, ER, and PR were detected in all 18 samples of leiomyoma and corresponding myometrial tissue collected in this study. Interestingly, in contrast to healthy tissues, we found a distinct and significant reduction of c-fos mRNA in the tumor. These data were substantiated by the finding of lowered c-Fos protein levels in leiomyomas tissues. Moreover, transcripts of c-jun and c-myc were less abundant in most of the leiomyomas than in the myometrium. This different expression of the protooncogenes in leiomyomas and myometrium was independent of the phase of the menstrual cycle in which samples were collected. In contrast to the reduced transcript levels observed for the immediate early genes, the ER and PR mRNA contents of the leiomyomas and myometrium did not differ. These results were confirmed by immunohistochemical studies for ER and PR protein.

In conclusion, our data show that the deregulated expression of protooncogenes, especially of c-fos, is linked to the pathogenesis of leiomyomas. Confirmation of a potential role of downregulated c-fos levels for the benign character of these tumors requires further investigation. Additionally, the findings suggest that sex steroids do not influence the different expression patterns of c-fos, c-myc, and c-jun in leiomyomas, as compared with myometrium.

This article has been cited by other articles:

				K. Yamazaki, M. Shimizu, M. Okuno, R. Matsushima-Nishiwaki, N. Kanemura, H. Araki, H. Tsurumi, S. Kojima, I B. Weinstein, and H. Moriwaki Synergistic effects of RXR{alpha} and PPAR{gamma} ligands to inhibit growth in human colon cancer cells phosphorylated RXR{alpha} is a critical target for colon cancer management Gut, November 1, 2007; 56(11): 1557 - 1563. [Abstract] [Full Text] [PDF]

				S. Hussein-Fikret, P. J. Fuller, and C. E. Gargett Expression of Steroid Receptor Coactivators in Cultured Cells From Paired Myometrial and Fibroid Tissues Reproductive Sciences, September 1, 2005; 12(6): 445 - 451. [Abstract] [PDF]

				L. Ding, J. Xu, X. Luo, and N. Chegini Gonadotropin Releasing Hormone and Transforming Growth Factor {beta} Activate Mitogen-Activated Protein Kinase/Extracellularly Regulated Kinase and Differentially Regulate Fibronectin, Type I Collagen, and Plasminogen Activator Inhibitor-1 Expression in Leiomyoma and Myometrial Smooth Muscle Cells J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5549 - 5557. [Abstract] [Full Text] [PDF]

				M. Shozu, K. Murakami, T. Segawa, T. Kasai, H. Ishikawa, K. Shinohara, M. Okada, and M. Inoue Decreased Expression of Early Growth Response-1 and Its Role in Uterine Leiomyoma Growth Cancer Res., July 1, 2004; 64(13): 4677 - 4684. [Abstract] [Full Text] [PDF]

				G. Weston, A. C. Trajstman, C. E. Gargett, U. Manuelpillai, B. J. Vollenhoven, and P. A.W. Rogers Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium Mol. Hum. Reprod., September 1, 2003; 9(9): 541 - 549. [Abstract] [Full Text] [PDF]

				N. Chegini, J. Verala, X. Luo, J. Xu, and R. S. Williams Gene Expression Profile of Leiomyoma and Myometrium and the Effect of Gonadotropin Releasing Hormone Analogue Therapy Reproductive Sciences, April 1, 2003; 10(3): 161 - 171. [Abstract] [PDF]

				S. Palomba, T. Russo, F. Orio Jr, L. Tauchmanova, E. Zupi, P. L. B. Panici, C. Nappi, A. Colao, G. Lombardi, and F. Zullo Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial Hum. Reprod., December 1, 2002; 17(12): 3213 - 3219. [Abstract] [Full Text] [PDF]

				S. Palomba, F. Orio Jr., M. Morelli, T. Russo, M. Pellicano, E. Zupi, G. Lombardi, C. Nappi, P. L. B. Panici, and F. Zullo Raloxifene Administration in Premenopausal Women with Uterine Leiomyomas: A Pilot Study J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3603 - 3608. [Abstract] [Full Text] [PDF]

				C. E. Gargett, K. Bucak, M. Zaitseva, S. Chu, N. Taylor, P. J. Fuller, and P. A.W. Rogers Estrogen receptor-{alpha} and -{beta} expression in microvascular endothelial cells and smooth muscle cells of myometrium and leiomyoma Mol. Hum. Reprod., August 1, 2002; 8(8): 770 - 775. [Abstract] [Full Text] [PDF]

				K. A. Kovacs, A. Oszter, P. M. Gocze, J. L. Kornyei, and I. Szabo Comparative analysis of cyclin D1 and oestrogen receptor ({alpha} and {beta}) levels in human leiomyoma and adjacent myometrium Mol. Hum. Reprod., November 1, 2001; 7(11): 1085 - 1091. [Abstract] [Full Text] [PDF]

				I. Gustavsson, K. Englund, M. Faxen, P. Sjoblom, B. Lindblom, and A. Blanck Tissue differences but limited sex steroid responsiveness of c-fos and c-jun in human fibroids and myometrium Mol. Hum. Reprod., January 1, 2000; 6(1): 55 - 59. [Abstract] [Full Text] [PDF]

				Y. Hennig, U. Deichert, U. Bonk, B. Thode, S. Bartnitzke, and J. Bullerdiek Chromosomal translocations affecting 12q14-15 but not deletions of the long arm of chromosome 7 associated with a growth advantage of uterine smooth muscle cells Mol. Hum. Reprod., December 1, 1999; 5(12): 1150 - 1154. [Abstract] [Full Text] [PDF]

				M. Klotzbucher, A. Wasserfall, and U. Fuhrmann Misexpression of Wild-Type and Truncated Isoforms of the High-Mobility Group I Proteins HMGI-C and HMGI(Y) in Uterine Leiomyomas Am. J. Pathol., November 1, 1999; 155(5): 1535 - 1542. [Abstract] [Full Text] [PDF]

				C. Benassayag, M. J. Leroy, V. Rigourd, B. Robert, J. C. Honore, T. M. Mignot, M. C. Vacher-Lavenu, C. Chapron, and F. Ferre Estrogen receptors (ERalpha /ERbeta ) in normal and pathological growth of the human myometrium: pregnancy and leiomyoma Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1112 - E1118. [Abstract] [Full Text] [PDF]